Literature DB >> 24488401

Disseminated fusariosis with endophthalmitis in a patient with hematologic malignancy.

Guilherme Fleury Perini, Luis Fernando Aranha Camargo, Claudio Luiz Lottenberg, Nelson Hamerschlak.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 24488401      PMCID: PMC4880399          DOI: 10.1590/s1679-45082013000400026

Source DB:  PubMed          Journal:  Einstein (Sao Paulo)        ISSN: 1679-4508


× No keyword cloud information.
A 68-year-old patient previously diagnosed with acute myeloid leukemia had fever and myalgia during chemotherapy. Despite broad spectrum antibiotics, fever persisted and, after 3 days, skin lesions compatible with Fusarium infection were seen on patients' lower limbs. Dyspnea and hypoxia were observed, and computerized tomography showed extensive pulmonary infiltrates; blood cultures were positive for Fusarium sp. A diagnosis of disseminated fusariosis was done, and lipossomal amphotericin, voriconazole and granulocyte infusion were initiated. The patient had complete regression of skin lesions and pulmonary infiltrates, but a week later he complained of visual blurring in the left eye. An orbital magnetic resonance imaging showed enhancement of left ocular globe with a lateral, medial and anterior delamination that was compatible with endophthalmitis (Figure 1). An intraocular treatment with voriconazole was applied and a little improvement was seen. Fusarium sp endophthalmitis affecting his right eye was diagnosed, which justified his visual loss. Despite treatment, a progressive worsening of bilateral endophthalmitis occurred and, to control the disease, the eye was enucleated. The pathological examination of the enucleated eye showed an intraocular abscess adjacent to the retina (Figure 2). In a higher magnification, Fusarium hyphae could be identified (Figure 3).
Figure 1

Orbit computerized tomography scan showing anterior, medial and lateral delamination of left eye, which was compatible with endophthalmitis

Figure 2

Anatomopathological exam of left eye showing intraocular abscess

Figure 3

In a higher magnification, Fusarium sp hyphae can be seen

Fusarium species cause a broad spectrum of infections in humans, including superficial, locally invasive, and disseminated infections. Immunocompromised patients are at higher risk, especially those with prolonged and severe neutropenia and/or severe T-cell immunodeficiency(. Patients with acute leukemia and patients undergoing hematopoetic stem cell transplantation are particularly at risk, especially to the invasive and disseminated( forms. The typical pattern of disseminated disease is a combination of cutaneous lesions (often with external necrosis in the center of the lesion), positive blood cultures, and with or without involvement at other sites (sinuses, lungs, and others)(. Fusarium endophthalmitis in the immunocompromised host usually results from hematogenous seeding(. Intraocular and systemic therapies often have poor responses. In order to avoid central nervous system involvement, the evisceration of the eye may be necessary(. Few case reports describe successful treatment of Fusarium sp endophthalmitis with voriconazole alone or in combination with caspofungin and posaconazole(.
  8 in total

1.  Disseminated Fusarium infection presenting as bilateral endogenous endophthalmitis in a patient with acute myeloid leukemia.

Authors:  Kourous A Rezai; Dean Eliott; Oren Plous; Jose A Vazquez; Gary W Abrams
Journal:  Arch Ophthalmol       Date:  2005-05

2.  Successful treatment of resistant ocular fusariosis with posaconazole (SCH-56592).

Authors:  Elmer Y Tu; David L McCartney; Richard F Beatty; Kathryn L Springer; Jaime Levy; Deepak Edward
Journal:  Am J Ophthalmol       Date:  2006-12-08       Impact factor: 5.258

3.  Successful treatment of Fusarium endophthalmitis with voriconazole and Aspergillus endophthalmitis with voriconazole plus caspofungin.

Authors:  Marlene L Durand; Ivana K Kim; Donald J D'Amico; John I Loewenstein; Ellis H Tobin; Shalom J Kieval; Stephen S Martin; Dimitri T Azar; Frederick S Miller; Brandon J Lujan; Joan W Miller
Journal:  Am J Ophthalmol       Date:  2005-09       Impact factor: 5.258

Review 4.  Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management.

Authors:  E I Boutati; E J Anaissie
Journal:  Blood       Date:  1997-08-01       Impact factor: 22.113

5.  Endogenous endophthalmitis following disseminated fungemia due to Fusarium solani in a patient with acute myeloid leukemia.

Authors:  Mario Tiribelli; Francesco Zaja; Carla Filì; Teresa Michelutti; Simonetta Prosdocimo; Anna Candoni; Renato Fanin
Journal:  Eur J Haematol       Date:  2002-05       Impact factor: 2.997

6.  Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management.

Authors:  Marcio Nucci; Elias Anaissie
Journal:  Clin Infect Dis       Date:  2002-09-18       Impact factor: 9.079

7.  Advanced fusarium keratitis progressing to endophthalmitis.

Authors:  Dilek Dursun; Viviana Fernandez; Darlene Miller; Eduardo C Alfonso
Journal:  Cornea       Date:  2003-05       Impact factor: 2.651

Review 8.  Fusarium infections in immunocompromised patients.

Authors:  Marcio Nucci; Elias Anaissie
Journal:  Clin Microbiol Rev       Date:  2007-10       Impact factor: 26.132

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.